3 Clinical Trials for Various Conditions
The primary objective of this study is to evaluate the incidence of hypoglycemia in adult and pediatric participants with glycogen storage disease type III (GSD III).
The primary objective of the study is to evaluate the safety of UX053 in adults with Glycogen Storage Disease Type III (GSD III).
The primary objective of this study is to evaluate potential biomarkers of GSD III.